Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

114
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
114
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

221
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
221
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

164
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
164
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

150
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
150
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

206
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
206
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

258
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial.

Kidney diseases (Basel, Switzerland)·2025
Same author

Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpoints.

BMC medical research methodology·2025
Same author

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

European journal of heart failure·2025
Same author

Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Diabetes, obesity & metabolism·2024

Related Experiment Video

Updated: Jul 14, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts.

Shuai Wang1, Robert Frederich2, James P Mancuso3

  • 1Pfizer Inc., 1 Portland St, Cambridge, MA, 02139, USA. shuai1107@hotmail.com.

Therapeutic Innovation & Regulatory Science
|October 7, 2023
PubMed
Summary

This study introduces a novel method for imputing missing time-to-event data in clinical trials using retrieved dropouts. This approach offers a robust alternative to traditional methods, enhancing the reliability of trial results.

Keywords:
Cardiovascular outcome trialEstimandInformative censoringMissing dataMultiple imputationProper imputationTime to event

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Jul 14, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Survival Analysis

Background:

  • Missing time-to-event data is a common challenge in long-term outcome trials.
  • Standard imputation methods often rely on assumptions like censoring at random (CAR), which may not always hold.
  • Robust statistical approaches are needed to handle missing data and ensure reliable trial results.

Purpose of the Study:

  • To propose and evaluate a novel statistical approach for imputing missing time-to-event data using retrieved dropouts.
  • To compare the performance of this new method against existing parametric and non-parametric imputation techniques.
  • To assess the robustness and computational efficiency of different imputation strategies.

Main Methods:

  • Proposed a multiple imputation framework using retrieved dropouts to model missing time-to-event data.
  • Compared parametric (MCMC, MLE) and non-parametric (bootstrap) imputation methods.
  • Evaluated type-I error and power rates across various scenarios.
  • Applied methods to a phase III CVOT dataset, comparing with Cox model and jump-to-reference imputation.

Main Results:

  • The proposed retrieved dropout imputation method demonstrated comparable or superior performance in simulations.
  • Parametric and non-parametric approaches showed different strengths regarding computational intensity and distributional assumptions.
  • The application to the CVOT dataset illustrated the practical utility and robustness of the proposed methods.

Conclusions:

  • Retrieved dropouts provide a reasonable basis for imputing missing time-to-event data in clinical trials.
  • The proposed multiple imputation approach offers a valuable alternative to standard methods, particularly when CAR assumption is questionable.
  • Further investigation into performance characteristics across diverse trial settings is warranted.